• Aucun résultat trouvé

for revising ivermectin treatment boundaries within the context of onchocerciasis elimination

N/A
N/A
Protected

Academic year: 2022

Partager "for revising ivermectin treatment boundaries within the context of onchocerciasis elimination "

Copied!
17
0
0

Texte intégral

Références

Documents relatifs

Table 12 Number of years and ivermectin treatment rounds to elimination with annual and biannual CDTI with different treatment coverage and complementary vector

The following tasks could be carried out by the Convention Secretariat through or supported by the expert group: facilitation of the provision of technical assistance to Parties

The fundamental considerations for providing high-quality contraceptive care to women and adolescent girls living with HIV include: (1) respecting, protecting and fulfilling human

There is the possibility of using the LoaScope as part of a model-based mapping strategy that would identify communities in areas that are hypoendemic for onchocerciasis that need

The three sampling methods used were: (i) purposive sampling of four communities with high prevalence (first- line villages) based on the 1997 REMO mapping (in each village,

Decision tree for stopping MDA as elimination programmes transition from phase 1 (treatment) to phase 2 (post-treatment surveillance) using both PCR in black fl ies and serology

x Based on two prospective observational studies, 9,10 skin snip microscopy, Ov-16 serology, ocular morbidity, and O-150 PCR (Poolscreen) in black flies reliably demonstrated

The interpretation of the survey data is not straightforward. As mentioned above, the required duration of treatment, and thus the time needed to reach the breakpoint,